Accustem Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ACUT and buy or sell other stocks, ETFs, and their options commission-free!About ACUT
AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. It also focuses on commercialization of a proprietary genomic test, StemPrintER, for patients with early-stage breast cancer.
CEOWendy Blosser
CEOWendy Blosser
Employees2
Employees2
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2020
Founded2020
Employees2
Employees2
ACUT Key Statistics
Market cap12.09M
Market cap12.09M
Price-Earnings ratio-6.45
Price-Earnings ratio-6.45
Dividend yield—
Dividend yield—
Average volume751.67
Average volume751.67
High today$0.79
High today$0.79
Low today$0.75
Low today$0.75
Open price$0.75
Open price$0.75
Volume730.00
Volume730.00
52 Week high$2.33
52 Week high$2.33
52 Week low$0.2159
52 Week low$0.2159
Stock Snapshot
The current Accustem Sciences(ACUT) stock price is $0.75, with a market capitalization of 12.09M. The stock trades at a price-to-earnings (P/E) ratio of -6.45.
As of 2025-12-10, Accustem Sciences(ACUT) stock has fluctuated between $0.75 and $0.79. The current price stands at $0.75, placing the stock 0.0% above today's low and -5.1% off the high.
Accustem Sciences(ACUT) shares are trading with a volume of 730, against a daily average of 751.67.
In the last year, Accustem Sciences(ACUT) shares hit a 52-week high of $2.33 and a 52-week low of $0.22.
In the last year, Accustem Sciences(ACUT) shares hit a 52-week high of $2.33 and a 52-week low of $0.22.